Erick A. Lindsey

643 total citations
16 papers, 380 citations indexed

About

Erick A. Lindsey is a scholar working on Infectious Diseases, Organic Chemistry and Molecular Biology. According to data from OpenAlex, Erick A. Lindsey has authored 16 papers receiving a total of 380 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 6 papers in Organic Chemistry and 5 papers in Molecular Biology. Recurrent topics in Erick A. Lindsey's work include Chemical Reactions and Isotopes (5 papers), Adenosine and Purinergic Signaling (3 papers) and Tuberculosis Research and Epidemiology (3 papers). Erick A. Lindsey is often cited by papers focused on Chemical Reactions and Isotopes (5 papers), Adenosine and Purinergic Signaling (3 papers) and Tuberculosis Research and Epidemiology (3 papers). Erick A. Lindsey collaborates with scholars based in United States, China and Germany. Erick A. Lindsey's co-authors include Christian Melander, Daniel C. Whitehead, Randall J. Basaraba, Roberta J. Melander, David F. Ackart, Akinori Okano, Karen Collins, Alex W. Schammel, Dale L. Boger and Atsushi Nakayama and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and Journal of Medicinal Chemistry.

In The Last Decade

Erick A. Lindsey

16 papers receiving 376 citations

Peers

Erick A. Lindsey

OC

MB

ID

EPIDE

MM

Pavel N. Solyev Russia

Ilona Bereczki Hungary

Kelly S.E. Tanaka United States

Baiyuan Yang United States

Matthew R. Birck United States

Raghunandan Yendapally United States

Sushil K. Maurya India

Arundhati Maitra United Kingdom

Clifford E. Soll United States

Mohamad Sabbah France

Pavel N. Solyev Russia

Erick A. Lindsey

250 ×1.7

OC

170 ×1.2

MB

96 ×1.0

ID

64 ×1.2

EPIDE

17 ×0.3

MM

Citations per year, relative to Erick A. Lindsey Erick A. Lindsey (= 1×) peers Pavel N. Solyev

Countries citing papers authored by Erick A. Lindsey

Since Specialization

Citations

This map shows the geographic impact of Erick A. Lindsey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erick A. Lindsey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erick A. Lindsey more than expected).

Fields of papers citing papers by Erick A. Lindsey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erick A. Lindsey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erick A. Lindsey. The network helps show where Erick A. Lindsey may publish in the future.

Co-authorship network of co-authors of Erick A. Lindsey

This figure shows the co-authorship network connecting the top 25 collaborators of Erick A. Lindsey. A scholar is included among the top collaborators of Erick A. Lindsey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erick A. Lindsey. Erick A. Lindsey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

1.

France, Scott P., Erick A. Lindsey, Emma L. McInturff, et al.. (2025). Synthetic Approaches to the New Drugs Approved during 2023. Journal of Medicinal Chemistry. 68(3). 2147–2182. 2 indexed citations

2.

France, Scott P., Erick A. Lindsey, Emma L. McInturff, et al.. (2024). Synthetic Approaches to the New Drugs Approved During 2022. Journal of Medicinal Chemistry. 67(6). 4376–4418. 15 indexed citations

3.

McInturff, Emma L., Scott P. France, Carolyn A. Leverett, et al.. (2023). Synthetic Approaches to the New Drugs Approved During 2021. Journal of Medicinal Chemistry. 66(15). 10150–10201. 14 indexed citations

4.

Flick, Andrew C., Carolyn A. Leverett, Hong X. Ding, et al.. (2022). Synthetic Approaches to the New Drugs Approved During 2020. Journal of Medicinal Chemistry. 65(14). 9607–9661. 24 indexed citations

5.

Sharif, Ehesan U., Jarosław Kalisiak, Kenneth V. Lawson, et al.. (2021). Discovery of Potent and Selective Methylenephosphonic Acid CD73 Inhibitors. Journal of Medicinal Chemistry. 64(1). 845–860. 26 indexed citations

6.

Flick, Andrew C., Carolyn A. Leverett, Hong X. Ding, et al.. (2021). Synthetic Approaches to the New Drugs Approved during 2019. Journal of Medicinal Chemistry. 64(7). 3604–3657. 33 indexed citations

7.

Blackledge, Meghan S., Erick A. Lindsey, David F. Ackart, et al.. (2017). The Discovery of 2‐Aminobenzimidazoles That Sensitize Mycobacterium smegmatis and M. tuberculosis to β‐Lactam Antibiotics in a Pattern Distinct from β‐Lactamase Inhibitors. Angewandte Chemie. 129(14). 3998–4002. 1 indexed citations

8.

Tan, Joanne B.L., Ada Chen, Manmohan R. Leleti, et al.. (2017). Abstract B46: Small-molecule inhibitors of ecto-nucleotidase CD73 promote activation of human CD8+ T cells and have profound effects on tumor growth and immune parameters in experimental tumor models. Cancer Immunology Research. 5(3_Supplement). B46–B46. 1 indexed citations

9.

Blackledge, Meghan S., Erick A. Lindsey, David F. Ackart, et al.. (2017). The Discovery of 2‐Aminobenzimidazoles That Sensitize Mycobacterium smegmatis and M. tuberculosis to β‐Lactam Antibiotics in a Pattern Distinct from β‐Lactamase Inhibitors. Angewandte Chemie International Edition. 56(14). 3940–3944. 23 indexed citations

10.

Okano, Akinori, Atsushi Nakayama, Erick A. Lindsey, et al.. (2015). Total Syntheses and Initial Evaluation of [Ψ[C(═S)NH]Tpg⁴]vancomycin, [Ψ[C(═NH)NH]Tpg⁴]vancomycin, [Ψ[CH₂NH]Tpg⁴]vancomycin, and Their (4-Chlorobiphenyl)methyl Derivatives: Synergistic Binding Pocket and Peripheral Modifications for the Glycopeptide Antibiotics. Journal of the American Chemical Society. 137(10). 3693–3704. 56 indexed citations

11.

Garrido, Carmen, Carrie A. Simpson, Noelle Dahl, et al.. (2015). Gold Nanoparticles to Improve HIV Drug Delivery. Future Medicinal Chemistry. 7(9). 1097–1107. 59 indexed citations

12.

Ackart, David F., Erick A. Lindsey, Brendan K. Podell, et al.. (2014). Reversal ofMycobacterium tuberculosisphenotypic drug resistance by 2-aminoimidazole-based small molecules. Pathogens and Disease. 70(3). 370–378. 36 indexed citations

13.

Lindsey, Erick A., et al.. (2012). The discovery of N-1 substituted 2-aminobenzimidazoles as zinc-dependent S. aureus biofilm inhibitors. MedChemComm. 3(11). 1462–1462. 20 indexed citations

14.

Lindsey, Erick A., et al.. (2011). 2-Aminopyrimidine as a novel scaffold for biofilm modulation. Organic & Biomolecular Chemistry. 10(13). 2552–2552. 21 indexed citations

15.

Rogers, Steven A., et al.. (2010). Synthesis and biological evaluation of 2-aminoimidazole/carbamate hybrid anti-biofilm and anti-microbial agents. Bioorganic & Medicinal Chemistry Letters. 21(4). 1257–1260. 27 indexed citations

16.

Ngassa, Felix N., Erick A. Lindsey, & Brandon E. Haines. (2009). The first Cu- and amine-free Sonogashira-type cross-coupling in the C-6-alkynylation of protected 2′-deoxyadenosine. Tetrahedron. 65(21). 4085–4091. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact